About 53,070 results

ALLMedicine™ Gastric Cancer Center

Research & Reviews  17,918 results

Demethylase FTO enhances the PI3K/Akt signaling to promote gastric cancer malignancy.
Medical Oncology (Northwood, London, England); Zhu Y, Yang J et. al.

Mar 28th, 2023 - Enhanced expression of fat mass and obesity-associated protein (FTO) has been reported in gastric cancer (GC). Bioinformatical studies indicate that FTO expression is correlated with the patients' overall survival (OS). How FTO exerts its promotio...

The cytosolic DNA sensor AIM2 promotes Helicobacter-induced gastric pathology via the i...
Immunology and Cell Biology; Dawson RE, Deswaerte V et. al.

Mar 28th, 2023 - Helicobacter pylori (H. pylori) infection can trigger chronic gastric inflammation perpetuated by overactivation of the innate immune system, leading to a cascade of precancerous lesions culminating in gastric cancer (GC). However, key regulators ...

Quantitative parameters in novel spectral computed tomography: Assessment of Ki-67 expr...
World Journal of Gastroenterology; Mao LT, Chen WC et. al.

Mar 28th, 2023 - The level of Ki-67 expression has served as a prognostic factor in gastric cancer. The quantitative parameters based on the novel dual-layer spectral detector computed tomography (DLSDCT) in discriminating the Ki-67 expression status are unclear. ...

Diagnosis and treatment for gastro-oesophageal cancer in England and Wales: analysis of...
The British Journal of Surgery; Pucher PH, Park MH et. al.

Mar 28th, 2023 - The National Oesophago-Gastric Cancer Audit (NOGCA) captures patient data from diagnosis to end of primary treatment for all patients with oesophagogastric (OG) cancer in England and Wales. This study assessed changes in patient characteristics, t...

SPI1 Mediates N-Myristoyltransferase 1 to Advance Gastric Cancer Progression via PI3K/A...
Canadian Journal of Gastroenterology & Hepatology; Qiu P, Li X et. al.

Mar 28th, 2023 - Gastric cancer (GC) is a common digestive tract malignancy worldwide. N-myristoyltransferase 1 (NMT1) has been implicated in many cancers, but its association with gastric cancer remains to be clarified. Thus, this paper elucidated the role of NMT...

see more →

Guidelines  25 results

Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of Oncology : Official Journal of the European Soc... Lordick F, Carneiro F et. al.

Aug 2nd, 2022 - Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.|2022|Lordick F,Carneiro F,Cascinu S,Fleitas T,Haustermans K,|diagnosis,epidemiology,therapy,

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JN... Ajani JA, D'Amico TA et. al.

Feb 8th, 2022 - Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type. Gastric cancer generally carries a poor p...

ACR Appropriateness Criteria® Epigastric Pain.
Journal of the American College of Radiology : JACR; , Vij A et. al.

Nov 20th, 2021 - Epigastric pain can have multiple etiologies including myocardial infarction, pancreatitis, acute aortic syndromes, gastroesophageal reflux disease, esophagitis, peptic ulcer disease, gastritis, duodenal ulcer disease, gastric cancer, and hiatal h...

AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Exp...
Gastroenterology Shah SC, Piazuelo MB et. al.

Aug 30th, 2021 - The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis du...

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021,...
Journal of the National Comprehensive Cancer Network : JN... Daly MB, Pal T et. al.

Jan 7th, 2021 - The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants associated with increased risk of breast, ovarian, and pancreatic cancer and r...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  1,848 results

Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer

Mar 23rd, 2023 - Background: According to Global Cancer Statistics of International Agency for Research on Cancer under World Health Organization, stomach cancer is the fifth most common cancer as there were over 1 million new cases in 2018 and the third leading c...

Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers

Mar 23rd, 2023 - Background: Hereditary Diffuse Gastric Cancer (HDGC) is most often attributed to inactivating germline mutations in the E-cadherin (CDH1) tumor suppressor gene. Mutation carriers have a 24-70% lifetime risk of developing gastric adenocarcinoma. In...

A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors

Mar 21st, 2023 - All tumor types are now closed for enrollment: Triple Negative Breast Cancer Gastric Cancer Pancreatic Cancer Small Cell Lung Cancer Bladder Cancer Ovarian Cancer

Specialization in Gastric Cancer Surgery

Mar 21st, 2023 - Specialization is having sufficient and effective knowledge on a subject. Today, in the medical world, specialization is defined as having competent knowledge on a disease, and in recent years, the benefit of specialization has begun to be emphasi...

An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

Mar 17th, 2023 - The purpose of the study is to assess the safety, tolerability and effectiveness of experimental medication BMS-986016 administered alone and in combination with nivolumab in patients with solid tumors that have spread and/or cannot be removed by ...

see more →

News  1,424 results

Laparoscopy, Surgery in a Draw for Gastric Cancer Survival

Mar 15th, 2023 - Relapse-free survival (RFS) data at 5 years showed that laparoscopy-assisted distal gastrectomy (LADG) was noninferior to open distal gastrectomy (ODG) in locally advanced gastric cancer, according to a phase II/III randomized trial from Japan. Am...

Study Supports Routine Omentectomy in Absence of Metastasis During CRS-HIPEC

Jan 11th, 2023 - Almost one-third of patients undergoing omentectomy for peritoneal metastases had occult omental metastases, supporting routine omentectomy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), authors of a retr...

Bariatric Surgery May Reduce Risk of Esophageal, Gastric Cancers

Jan 11th, 2023 - Undergoing bariatric surgery for severe obesity was linked to a decreased incidence of esophageal and gastric cancer and overall in-hospital mortality, a French cohort study showed. Among mostly women, the incidence rates of these cancers were 4.9...

The Role of Cultural Humility in Addressing Disparities in Lung Cancer Treatment: How Can Physicians Make a Difference?

Dec 13th, 2022 - This transcript has been edited for clarity. Jacob Sands, MD: I'm Dr Jacob Sands, thoracic medical oncologist at the Dana-Farber Cancer Institute. Welcome to Medscape's InDiscussion series on lung cancer. Today, we'll be discussing disparities in ...

Frontline Pembrolizumab Plus Chemotherapy Meets OS End Point in HER2-Negative Gastric/GEJ Adenocarcinoma

Nov 22nd, 2022 - The combination of pembrolizumab (Keytruda) and physician’s choice of chemotherapy produced a statistically significant overall survival (OS) benefit vs chemotherapy plus placebo in patients with HER2-negative, locally advanced, unresectable or me...

see more →

Patient Education  9 results see all →